Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia

Leukemia Research

Volumn 21, Issue 3, 1997, Pages 249-253

  Aul, C ^a   Gattermann, N ^a   Germing, U ^a   Sudhoff T ^a   Hollmig, K A ^a   Heyll, A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chronic myelomonocytic leukemia; Hyperleukocytic syndrome; Leukocyte adhesion molecules; Low dose chemotherapy; Microvascular hyperviscosity; Myelodysplastic syndrome; Pulmonary circulation

Indexed keywords

CYTARABINE; LYSOZYME;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; ENZYME BLOOD LEVEL; ENZYMURIA; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG CIRCULATION; MALE; MICROCIRCULATION; MONOCYTOSIS; NEUROLOGIC DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKIN INFILTRATE; SPLENOMEGALY; VASCULAR ENDOTHELIUM;

FATAL OUTCOME; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKOCYTOSIS; MALE; MIDDLE AGED; SYNDROME;

EID: 0030956284     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00117-8     Document Type: Article

References (19)

1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R. & Sultan C. (1982) Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51, 189.
2. Michaux J. L. & Martiat P. (1993) Chronic myelomonocytic leukaemia (CMML) - a myelodysplastic or myeloproliferative syndrome? Leukemia Lymphoma 9, 35.
3. Groupe Français de Cytogénétique Hématologique (1986) Cytogenetics of chronic myelomonocytic leukemia. Cancer Genet and Cytogenet 21, 11.
4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H., Sultan C. & Cox C. (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French-Amcrican-British Cooperative Leukaemia Group. Br. J. Haematol. 87, 746.
5. Foucar K., Langdon R. M., Armitage J. O., Olson D. B. & Carroll T. J. (1985) Myelodysplastic syndromes: a clinical and pathologic analysis of 109 cases. Cancer 56, 553.
6. Kerkhofs H., Hermans I., Haak H. L. & Leeksma C. H. W. (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br. J. Haematol. 65, 73.
7. Aul C., Gattermann N., Heyll A., Germing U., Derigs G. & Schneider W. (1992) Primary myelodysplastic syndromes (MDS): analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6, 52.
8. Gattermann N. & Schneider W. (1991) Leukostase-Syndrom. Dtsch. Med. Wochenschr. 116, 1399.
9. Van Buchem M. A., Te Velde J., Willemze R. & Spaander R. J. (1988) Leucostasis, an under-estimated cause of death in leukaemia. Blut 56, 39.
10. Lichtman M. A., Heal J. & Rowe J. M. (1987) Hyperleukocytic leukaemia: Theological and clinical features and management. Baillière's Clin. Haematol. 1, 725.
11. Preston F. E., Sokol R. J., Lilleyman J. S., Winfield D. A. & Blackburn E. K. (1978) Cellular hyperviscosity as a cause of neurologic symptoms in leukaemia. Br. Med. J. 1, 476.
12. Lichtman M. A. & Kearney E. A. (1976) The filterability of normal and leukemic leukocytes. Blood Cells 2, 491.
13. Zittoun R. (1992) Chronic mydomonocytic leukaemia. In The Myelodysplastic Syndromes (Mufti G. J. & Galton D. A. G., Eds), p. 65. Churchill Livingstone, Edinburgh.
14. Germing U., Gattermann N., Runde V., Heyll A., Jaeger M., Schneider W. & Aul C. (1994) Prognostic value of the Düsseldorf score in 735 untreated patients with primary myelodysplastic syndromes. Blood 84 (suppl.), 1243.
15. Geller S. A. (1971) Acute leukemia presenting as respiratory distress. Arch. Pathol. 91, 573.
16. Vernant J. P., Brun B., Mannoni P. & Dreyfus B. (1979) Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 44, 264.
17. Everson M. P., Brown C. B. & Lily M. B. (1989) Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells. Blood 74, 1472.
18. Springer T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301.
19. Südhoff T., Aul C., Runde V., Wehmeier A. & Schneider W. (1995) Levels of circulating leukocyte adhesion molecules in patients with myelodysplastic syndrome. Exp. Hematol. 23, 919.